Ottobock

Belkins
All over the world, the name Ottobock is a synonym for high-quality and technologically outstanding medical technology products and services. The goal of helping to restore mobility to people with disabilities, and protect what mobility they have, stands behind each and every one of the company's products. Our conviction that quality of life is closely connected to a maximum of individual freedom and independence is a key concept that has been a major influence throughout the company's nearly 100-year history and guides the development of new products in a focused manner.

Related News

ORION BIOTECHNOLOGY SUCCESSFULLY ACCOMPLISHES PHASE 1 CLINICAL TRIAL OF A FIRST-IN-CLASS PRECISION ENGINEERED LIGAND ANALOG FOR HIV PREVENTION

Orion Biotechnology Canada Ltd | October 16, 2020

news image

Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company focused on precision engineering GPCR-targeted therapeutics, today announced the results of their Phase 1 study of OB-002H which is an investigational candidate microbicide for HIV prevention. The Phase 1 study was a first-in-man trial designed to evaluate the safety, acceptability, and pharmacokinetic profile of OB-002H gel. OB-002, a highly potent chemokine analog of CCL5 (a ligand for the CCR5 HIV co-receptor), has previ...

Read More

MEDICAL MORPHINE MARKET MAY SEE A BIG MOVE PFIZER, PURDUE PHARMA, HIKMA PHARMACEUTICALS

openPR | April 08, 2020

news image

Advance Market Analytics released the research report of Global Medical Morphine Market, offers a detailed overview of the factors influencing the global business scope. Medical Morphine Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Medical Morphine. This Report covers the emerging player's data, including: competitive situatio...

Read More

TRUMP FULFILLED A LONGSTANDING CAMPAIGN PROMISE TO LOWER DRUG PRICES

East Idaho News | July 20, 2020

news image

President Donald Trump fulfilled to a longstanding campaign promise Friday — to lower drug prices. He signed four executive orders, including ones on importing medications from Canada and basing the cost of drugs in the US on their prices in other countries — both of which progressive Democrats, including Vermont Sen. Bernie Sanders, have pushed. The efforts, which largely reaffirm the policies of the administration, are unlikely to have an effect before...

Read More

DECK 7 INTERVIEWS SANGRAM VAJRE, CO-FOUNDER & CHIEF EVANGELIST AT TERMINUS

DECK 7 | February 04, 2020

news image

DECK 7 is proud to present an exciting interview with the Co-Founder & Chief Evangelist at Terminus, Sangram Vajre. He is an author, keynote speaker, 3x CMO, host of the daily #FlipMyFunnel podcast, entrepreneur and category maker. Sangram has been a driving force behind the success of Terminus and building the ABM subcategory of marketing technology. Before co-founding Terminus, Sangram was Head of Marketing at Pardot through its acquisition by ExactTarget and then Salesforce. A contributin...

Read More

Orion Biotechnology Canada Ltd | October 16, 2020

news image

ORION BIOTECHNOLOGY SUCCESSFULLY ACCOMPLISHES PHASE 1 CLINICAL TRIAL OF A FIRST-IN-CLASS PRECISION ENGINEERED LIGAND ANALOG FOR HIV PREVENTION

Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company focused on precision engineering GPCR-targeted therapeutics, today announced the results of their Phase 1 study of OB-002H which is an investigational candidate microbicide for HIV prevention. The Phase 1 study was a first-in-man trial designed to evaluate the safety, acceptability, and pharmacokinetic profile of OB-002H gel. OB-002, a highly potent chemokine analog of CCL5 (a ligand for the CCR5 HIV co-receptor), has previ...

Read More

openPR | April 08, 2020

news image

MEDICAL MORPHINE MARKET MAY SEE A BIG MOVE PFIZER, PURDUE PHARMA, HIKMA PHARMACEUTICALS

Advance Market Analytics released the research report of Global Medical Morphine Market, offers a detailed overview of the factors influencing the global business scope. Medical Morphine Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Medical Morphine. This Report covers the emerging player's data, including: competitive situatio...

Read More

East Idaho News | July 20, 2020

news image

TRUMP FULFILLED A LONGSTANDING CAMPAIGN PROMISE TO LOWER DRUG PRICES

President Donald Trump fulfilled to a longstanding campaign promise Friday — to lower drug prices. He signed four executive orders, including ones on importing medications from Canada and basing the cost of drugs in the US on their prices in other countries — both of which progressive Democrats, including Vermont Sen. Bernie Sanders, have pushed. The efforts, which largely reaffirm the policies of the administration, are unlikely to have an effect before...

Read More

DECK 7 | February 04, 2020

news image

DECK 7 INTERVIEWS SANGRAM VAJRE, CO-FOUNDER & CHIEF EVANGELIST AT TERMINUS

DECK 7 is proud to present an exciting interview with the Co-Founder & Chief Evangelist at Terminus, Sangram Vajre. He is an author, keynote speaker, 3x CMO, host of the daily #FlipMyFunnel podcast, entrepreneur and category maker. Sangram has been a driving force behind the success of Terminus and building the ABM subcategory of marketing technology. Before co-founding Terminus, Sangram was Head of Marketing at Pardot through its acquisition by ExactTarget and then Salesforce. A contributin...

Read More